Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

ABSTRACT: This is Phase Ib/II, multicenter, open-label adaptive platform study of JDQ443 with select therapies in patients with advanced solid tumors harboring the KRAS G12C mutation.

DISEASE(S): Colorectal Tumors,Carcinoma, Non-small Cell Lung,Carcinoma,Malignant Solid Tumor,Kras G12c Mutant Solid Tumors,Colorectal Cancer,Advanced Solid Tumors,Lung Neoplasms,Neoplasms,Nonsmall Cell Lung Cancer,Colorectal Carcinoma,Neoplasms, Colorectal,Kras Mutation,Nsclc,Non-small Cell Lung Cancer,Colorectal Neoplasms,Carcinoma, Non-small-cell Lung,Non-small Cell Lung Carcinoma,Adult Patients With Advanced (metastatic Or Unresectable) Kras G12c Mutant Solid Tumors

PROVIDER: 2726548 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR